eicosapentaenoic acid ethyl ester has been researched along with Affective Psychosis, Bipolar in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarris, J | 1 |
| Keck, PE | 1 |
| Mintz, J | 1 |
| McElroy, SL | 1 |
| Freeman, MP | 1 |
| Suppes, T | 1 |
| Frye, MA | 1 |
| Altshuler, LL | 1 |
| Kupka, R | 1 |
| Nolen, WA | 1 |
| Leverich, GS | 1 |
| Denicoff, KD | 1 |
| Grunze, H | 1 |
| Duan, N | 1 |
| Post, RM | 1 |
| Upton, I | 1 |
| Frangou, S | 1 |
| Lewis, M | 1 |
| Wollard, J | 1 |
| Simmons, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder[NCT04210804] | Phase 2 | 80 participants (Actual) | Interventional | 2014-04-01 | Completed | ||
| Targeted Alterations in n-3 and n-6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder[NCT02272010] | 83 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for eicosapentaenoic acid ethyl ester and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Double-Blind Method; Eicosapentaenoic Acid; Female; | 2006 |
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Double-Blind Method; Eicosapentaenoic Acid; Female; | 2006 |
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Double-Blind Method; Eicosapentaenoic Acid; Female; | 2006 |
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Double-Blind Method; Eicosapentaenoic Acid; Female; | 2006 |
Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder.
Topics: Adult; Aspartic Acid; Bipolar Disorder; Brain; Double-Blind Method; Eicosapentaenoic Acid; Female; H | 2007 |
2 other studies available for eicosapentaenoic acid ethyl ester and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders.
Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Dietary Supplements; Eicosapentaenoic Acid | 2017 |
Ethyl-eicosapentaenoic acid in bipolar depression.
Topics: Antipsychotic Agents; Bipolar Disorder; Eicosapentaenoic Acid; Humans; Treatment Outcome | 2006 |